Friday, 22 Jun 2018

You are here

Shoe Inserts Disappoint with Plantar Heel Pain

A report from the British Journal of Sports Medicine shows that commonly used drug store shoe inserts or customized orthotics are often ineffective in managing plantar heel pain. (Citation source bit.ly/2puzUbm)

Reuters reports on the results of a study addressing plantar heel pain that accounts for as much as 15% of foot symptoms  and 10% of running injuries. 

A systematic review of the literature included 20 randomized controlled trials comparing foot orthoses with a control population (either no intervention, sham or other conservative treatment) in patients with plantar heel pain (PHP).

Six studies showed no difference in short-term outcomes between prefabricated orthoses and sham orthoses for pain.

No difference was found between prefabricated orthoses and custom orthoses for pain at short term.

Results suggests that orthotics might work for some people, but not others, and that time, rather than the insert, may be most important in the ultimate outcomes.

Other options for patients with PHP includes the use of night splints, stretching exercises, supervised physical therapy or modification of exercise and lifestyle.

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

EULAR 2018 - Day 3 Report

Day 3 highlights include Behcet’s responds to apremilast and that biologics do not differentially affect TKR/THR post-operative infection rates. Be sure to check out today's podcast as well. 

Canada Closer to Marijuana Approval

Reuters reports that Canada’s Senate on Thursday voted to legalize recreational marijuana, clearing a major hurdle that puts the country on track to become the first Group of Seven nation to permit national use of the drug.

Now the law and amendments go to the House of Commons who will need to decide on before the law can be passed.

Advance Practice Clinicians Proliferating in Specialty Practices

An analysis of SK&A outpatient provider files, covering 90% of physician practices in the United States, shows that between 2008 to 2016, there was a 22% increase in the employment of advanced practice clinicians (APCs) by specialty practices.  By 2016, 28% of all specialty practices employed APCs.

Trump Blasts Drug Makers on the Price of Drugs

Reuter's reports Friday that President Donald Trump blasted drugmakers and healthcare “middlemen” for making prescription drugs unaffordable for Americans. Nonetheless, many healthcare stocks rose as it became clear the administration had avoided taking aggressive and direct measures to cut drug prices.

Here are many New Sources on this developing story:

Patients May Not Fill Your Prescription

A new study linking administrative claims and electronic health records (EHRs) shows that nearly 40% of patients fill and take newly prescribed methotrexate (MTX), tofacitinib or biologics. 

Kan et al set out to estimate the extent and predictors of primary nonadherence in rheumatoid arthritis (RA) patients who received new prescriptions for methotrexate, biologics or tofacitinib.